Health Care & Life Sciences » Pharmaceuticals | Sun Pharma Advanced Research Co.

Sun Pharma Advanced Research Co. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
1,670
1,557
1,613
1,810
783
Cost of Goods Sold (COGS) incl. D&A
1,317
1,881
2,164
2,673
2,671
Gross Income
354
323
551
862
1,888
SG&A Expense
51
97
149
444
618
EBIT
299
422
704
-
2,508
Unusual Expense
1
1
-
1
1
Non Operating Income/Expense
60
1
19
18
531
Interest Expense
56
2
22
18
1
Pretax Income
343
395
700
1,190
1,970
Income Tax
40
-
-
-
-
Consolidated Net Income
303
395
700
1,190
1,970
Net Income
303
395
700
1,190
1,970
Net Income After Extraordinaries
303
395
700
1,190
1,970
Net Income Available to Common
303
395
700
1,190
1,970
EPS (Basic)
1.27
1.66
2.96
4.84
7.94
Basic Shares Outstanding
238
238
237
246
248
EPS (Diluted)
1.27
1.66
2.96
4.84
7.94
Diluted Shares Outstanding
238
238
237
246
248
EBITDA
338
347
626
1,225
2,426
Other Operating Expense
3
1
4
2
2
Non-Operating Interest Income
39
28
7
116
6

About Sun Pharma Advanced Research

View Profile
Address
17 B Mahal Industrial Estate
Mumbai Maharashtra 400093
India
Employees -
Website http://www.sunpharma.in
Updated 09/14/2018
Sun Pharma Advanced Research Co. Ltd. is a bio-pharmaceutical company, which engages in the research and development of pharmaceuticals. Its projects include new chemical entity research and novel drug delivery systems. The company was founded on March 1, 2006 and is headquartered in Mumbai, India.